What Is Methanofuran? Definition and What Research Reports

Definition

Methanofuran is a small, non-protein coenzyme used by methanogenic archaea (and some related anaerobes) as the first carrier of a single carbon atom during methane formation and carbon dioxide fixation. In plain terms: it is the molecule that grabs CO₂, holds it as a formyl group on its terminal amine, and hands that carbon unit on to the next coenzyme in the pathway. Its name comes from its chemistry, not from any protein or hormone — a furan ring sits at the reactive end of the molecule, attached to a longer, amino-acid-containing tail. Methanofuran is not a peptide drug, not a peptide hormone, and not an ingredient in human clinical research; it is a microbial cofactor studied in enzymology, structural biology and archaeal genetics.

What Class of Molecule It Is

Methanofuran belongs to the family of C1-carrier coenzymes — small organic cofactors that shuttle one-carbon units between enzymes. Related members of that family include tetrahydromethanopterin and coenzyme M. Structurally, methanofuran has two distinguishable parts:

• A reactive furan head group. The 5-(aminomethyl)-3-furanmethanol moiety carries the free amine where the one-carbon unit becomes attached; researchers reconstructed the biosynthetic route to this moiety in Methanocaldococcus jannaschii and reported the enzymes and intermediates involved (PMID 24977328).
• An amino-acid-containing tail. The rest of the molecule includes glutamate residues joined through amide bonds, together with other small building blocks. One study characterised a tyramine-glutamate ligase, designated MfnD, and reported that it formed an amide bond between tyramine and glutamate as part of methanofuran assembly (PMID 25211225).

Because the tail contains amide-linked glutamate units, methanofuran is sometimes described loosely as "peptide-like" or as having a peptidyl side chain. That descriptive similarity is the main reason the term surfaces alongside peptide chemistry vocabulary. It remains a coenzyme built by dedicated biosynthetic enzymes, not a ribosomally synthesised peptide.

Where It Comes From

Methanofuran is made inside the cells that use it. The best-studied source organisms are hydrogenotrophic methanogens — archaea that reduce CO₂ to methane using hydrogen — with Methanocaldococcus jannaschii serving as a common genetic and biochemical model. Work on that organism identified the final two genes required to complete methanofuran biosynthesis, and the authors reported functional assignments for the encoded proteins (PMID 26100040). Precursor supply has also been examined: one study investigated β-alanine biosynthesis in M. jannaschii and reported the route by which this small building block, relevant to coenzyme biosynthesis in methanogens, was produced (PMID 24891443). An earlier report identified an archaeal 2-hydroxy acid dehydrogenase that catalysed reactions in coenzyme biosynthesis in methanoarchaea (PMID 10850983). More recently, an analysis of Methanosarcina mazei examined coenzyme metabolism across methanogen lineages and reported patterns the authors interpreted as convergent evolution and metabolic adaptation (PMID 40051064).

How the Term Is Used in Peptide and Biochemistry Literature

Within the published literature, "methanofuran" is used almost exclusively as a biochemical noun in three contexts:

1. As a substrate name. Enzymes are named after it — formylmethanofuran dehydrogenase (Fmd or Fwd) attaches the carbon unit, and formylmethanofuran:tetrahydromethanopterin formyltransferase (Ftr) moves it onward.
2. As a pathway marker. Detection of methanofuran or its biosynthesis genes is treated as evidence that an organism runs the methanogenic or reverse-methanogenic C1 pathway.
3. As a biosynthesis target. Papers describe how the molecule itself is assembled, including the amide-bond-forming ligase steps noted above.

What the term does not denote is a peptide sequence, a research peptide analogue, or any compound administered to research animals or people in the literature verified for this entry. Anyone encountering the word in a peptide glossary context should read it as archaeal cofactor chemistry. This page is for educational purposes only and is not medical advice; consult a licensed physician for any health question.

What the Published Literature Reports

The enzyme that loads carbon onto methanofuran

The first committed step of CO₂ fixation in methanogens is reduction of carbon dioxide and its attachment to methanofuran. A structural study of the methanogenic CO₂ reducing-and-fixing enzyme reported that the enzyme was bifunctional and contained 46 [4Fe-4S] clusters (PMID 27846502), an unusually large iron–sulfur inventory that the authors linked to long-range electron delivery. A separate computational study explored the mechanism of formylmethanofuran dehydrogenase and reported theoretical descriptions of the first reductive step in CO₂ fixation by methanogens (PMID 27456610). A later account in the chemistry literature reviewed formylmethanofuran dehydrogenases as a natural model for combined CO₂ capture and transformation (PMID 39584476).

Larger assemblies and the wider pathway

Methanofuran-handling enzymes do not always work alone. One study reported the isolation and structural characterisation of a three-megadalton complex of methanogenic electron-bifurcating and CO₂-fixing enzymes (PMID 34516836), describing how electron supply and carbon fixation were physically coupled. A review of the structural basis of hydrogenotrophic methanogenesis summarised the enzymes and coenzymes of the pathway, methanofuran among them, and reported how each structural step had been resolved (PMID 32692612).

Passing the carbon unit onward

Once formylated, methanofuran transfers its formyl group to tetrahydromethanopterin. A crystallographic study reported the structure of formylmethanofuran:tetrahydromethanopterin formyltransferase in complex with its coenzymes, defining how both cofactors were bound at the active site (PMID 16466742).

Terms Frequently Seen Beside It

Human and Safety Data: What Studies Report

The verified literature for this entry consisted of biochemical, structural, computational and microbial-genetics work carried out in archaeal systems, purified enzymes or in silico models. None of the cited studies reported administration of methanofuran to humans or laboratory animals, and none reported pharmacokinetics, dosing or adverse events. The methanofuran biosynthesis papers characterised genes and enzymes in Methanocaldococcus jannaschii (PMID 26100040, PMID 24977328), while the structural papers described enzyme architecture and coenzyme binding (PMID 27846502, PMID 34516836). Accordingly, no safety profile can be summarised from this body of work, and nothing here should be read as describing a product intended for human use.

Why It Appears in Applied Research Discussions

Interest outside microbiology comes mainly from carbon chemistry rather than biomedicine. Reviewers have framed formylmethanofuran dehydrogenase as an instructive natural system for capturing CO₂ and converting it in a single enzymatic setting, and reported design lessons drawn from its structure and metalloenzyme chemistry (PMID 39584476). Comparative genomics of coenzyme metabolism has also been used to argue about early metabolic evolution, with one analysis of Methanosarcina mazei reporting convergent routes to shared cofactors (PMID 40051064). Those are the discussion threads in which the word most often appears.

References

• Biosynthesis of the 5-(Aminomethyl)-3-furanmethanol moiety of methanofuran (Biochemistry, 2014)
• Identification and characterization of a tyramine-glutamate ligase (MfnD) involved in methanofuran biosynthesis (Biochemistry, 2014)
• Identification of the Final Two Genes Functioning in Methanofuran Biosynthesis in Methanocaldococcus jannaschii (Journal of Bacteriology, 2015)
• β-alanine biosynthesis in Methanocaldococcus jannaschii (Journal of Bacteriology, 2014)
• Identification of an archaeal 2-hydroxy acid dehydrogenase catalyzing reactions involved in coenzyme biosynthesis in methanoarchaea (Journal of Bacteriology, 2000)
• The structure of formylmethanofuran: tetrahydromethanopterin formyltransferase in complex with its coenzymes (Journal of Molecular Biology, 2006)
• Theoretical exploration of the mechanism of formylmethanofuran dehydrogenase: the first reductive step in CO2 fixation by methanogens (JBIC, 2016)
• The methanogenic CO2 reducing-and-fixing enzyme is bifunctional and contains 46 [4Fe-4S] clusters (Science, 2016)
• Three-megadalton complex of methanogenic electron-bifurcating and CO2-fixing enzymes (Science, 2021)
• Structural Basis of Hydrogenotrophic Methanogenesis (Annual Review of Microbiology, 2020)
• All-in-One CO2 Capture and Transformation: Lessons from Formylmethanofuran Dehydrogenases (Accounts of Chemical Research, 2024)
• Convergent Evolution of Coenzyme Metabolism in Methanosarcina mazei: Insights Into Primitive Life and Metabolic Adaptations (Journal of Basic Microbiology, 2025)